Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion type Assertion NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_head.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion description "[Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P<0.03 for all the cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_provenance.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion evidence source_evidence_literature NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_provenance.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion SIO_000772 21408220 NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_provenance.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion wasDerivedFrom befree-20140225 NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_provenance.
- NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_assertion wasGeneratedBy ECO_0000203 NP798097.RAk1-OGnQdYtWPDnRlLph2oBcDayhRU3HIL4HV-FbwJ4g130_provenance.